Sep 04, 2019 / 01:05PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Analyst
All right. Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with the management team from Edwards Lifesciences. With us, we have Mike Mussallem, Chairman and CEO; and Scott Ullem, Corporate Vice President and Chief Financial Officer; as well as Mark Wilterding, Vice President of Investor Relations. In terms of the format, it's going to be a fireside chat. If anyone has a question in the audience, please raise your hand and we will call on you. So Mike and Scott, thank you very much for being here again this year. Really appreciate it.
Michael A. Mussallem - Edwards Lifesciences Corporation - Chairman & CEO
Great.
Questions and Answers:
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior AnalystSo Mike, I thought we'd start kind of at a high level. It seems like Edwards is poised for strong continued growth in the
Trustpilot
